Tarun Sachdeva Email & Phone Number

Delhi, India

Delhi, India

• Grown the business from a base of $0.74M to $6.3M in a mix of Public and Corporate key accounts; and delivered >500% growth as an individual contributor by enrolling 600 new patients
• Led a special project – grown the business from a base of ₹15Lacs to ₹27Cr in Tier 3 Haryana market; brought >400% growth
• Spearheading a special marketing project for PHESGO®: Marketing Lead – PHESGO® Apr 2022 – Ongoing
• Project managed pre-launch activities, collaborated with insights partner to plan and conduct market research to gather specific insights via customer interactions and focus group surveys on competitive prices, demand.
• Designed impactful marketing collaterals (Visual aids, LBLs, administration grid card), ensured execution of brand strategy through differentiated in-clinic positioning and value messaging initiatives
• Developed annual brand plan and implemented marketing strategy in collaboration with all cross-functional teams, including PPOCs, medical affairs, insights & analytics, competitive intelligence, patient advocacy.

North & East

• Launched TAGRISSO in two major indications: 1L metastatic & early resected adjuvant EGFRm NSCLC
• Project managed pre-launch activities for EGFRm eNSCLC: patient journey in-sighting & belief mapping with top KOLs
• Developed the Zonal Marketing Strategy and implemented the tactical plan
• Co-created tactical strategy for increasing the DoT of TAGRISSO
• Successfully conducted 4 International Speaker Programs (ISPs), >20 promotional webinars during pandemic of COVID-19 engaging national KOLs for dissemination of science to ~300 Oncologists
• Contributed in development of pan-India go-to patient strategy considering the supply chain gaps during testing times of COVID-19 lock-downs and ensured that not a single patient on therapy misses any dose

New Delhi

• Grown the business from a base of $330K to $2.5M in a mix of Public and Corporate key accounts; and delivered >300% growth as an individual contributor by enrolling 179 new patients on TAGRISSO
• Achieved 135% secondary sales, surpassed all the MoM and QoQ targets and significantly contributed to TAGRISSO becoming a 100 crore brand
• Spearheaded zonal marketing project for launch of new indications of TAGRISSO

New Delhi

• Launched ABEVMY® – a biosimilar brand of Bevacizumab and enrolled 64 new patients from all key TAEs in corporate key accounts within a short span of 8 months

Mohali, Punjab, India

- Responsible for RSI updates for top pharma MNCs- CDS update, SmPC update, Signal detection & RMP

Chandigarh Area, India

• Succeeded major projects for top 5 globally renowned Pharma MNCs in collaboration with Global Safety Physicians to provide drug safety solutions for innovator as well as generic products
• Reviewed the patient safety data and provided aggregate report authoring services and PV inputs for Health Authority/Regulatory submission (Aggregate reports like PBRERs/PSURs, DSURs, Ad-hocs, aCOs, PADERs, HHEs, RSI.

New Delhi

• Managed a good mix of key Trade/Corporate as well as Institutional accounts in two of the largest metro cities in India Mumbai and Delhi NCR
• Grown the business of AVASTIN® to $1.4M at an annual growth of ~70% from year 2013 to 2015
• Launched THE BLUE TREE (Comprehensive Cancer Patient Assistance) Program to ~170 Oncologists

Mumbai & Delhi

• Managed a good mix of key Trade/Corporate as well as Institutional accounts like – Tata Memorial Hospital, INHS Asvini, Kokilaben Dhirubhai Ambani Hospital, Hinduja, HCG Nanavati, Fortis etc.

Post-Graduate Diploma In Business Management, Marketing, A

Activities and Societies: Marketing, Strategy, Management

Masters In Pharmacy, Pharmacology, A

Activities and Societies: Debate competitions, cultural activities and member of Placement CellPreclinical and clinical research

Bachelors In Pharmacy, Pharmacy, A

Activities and Societies: Member of Cultural Society, Debate group and placement cellPharmaceutical sciences: Pharmacology, Pharmaceutics.